Antidepressant cost: only 35.0% of US adults prescribed one for depression would stay on it at $150 a month, against 82.2% at $50
Cost and side effects: 82.2% of US adults prescribed an antidepressant for depression would stay on one that helps at $50 a month but 35.0% at $150, and 51.3% say a quick switch when side effects bother them would keep them on it (n=197, November 2026).
- Who was asked
- Healthcare, 197 clones, US
- When
- November 2026 (fielded 19 November 2026)
- How
- Predicted responses from Brox clones, each built from a long-form interview with a real person.
- What changed from the obvious question
- The obvious question is why people stop an antidepressant, which published surveys already answer with side effects and feeling better. We asked 197 clones of US adults who have been prescribed an antidepressant for depression how likely they would be to stay on one that is helping at $10, $50 and $150 a month, and what they would do first if the price jumped. That puts a price on the access side of staying on treatment, which those surveys do not.
Section 01: What the panel said
- #
35%
35.0% would stay on an antidepressant that is helping at $150 a month, against 82.2% at $50 and 97.0% at $10; no clone rates itself more likely to stay on at a higher price.
base 197
- #
18.2%
18.2% of the 88 adults with a household income under $35,000 would stay on at $150 a month, against 71.8% of the 39 above $75,000.
base 88 · Household income under $35,000 · contrast
- #
58.9%
58.9% would first ask their doctor to switch them to a cheaper antidepressant if its cost rose from $10 to $150 a month, 34.5% would look for a discount and 3.0% would stop; none of the 197 would take it less often to make it last.
base 197 · contrast
- #
51.3%
51.3% say being switched to a different antidepressant as soon as side effects bother them would do most to keep them on it, asked in general before any price; 14.2% pick a lower monthly cost.
base 197 · contrast
35.0% would stay on an antidepressant that is helping at $150 a month, against 82.2% at $50 and 97.0% at $10; no clone rates itself more likely to stay on at a higher price.
02Where does the cost of an antidepressant start to push people off it?
Between $50 and $150 a month. Of the 197 adults who have been prescribed an antidepressant for depression, 191 rate themselves likely to keep taking one that is helping at $10 a month, 162 at $50 and 69 at $150. The step from $10 to $50 loses 29 people, and the step from $50 to $150 loses 93 more, so most of the drop sits in the last step. Nobody moves back: no clone rates itself more likely to stay on at a higher price than at a lower one.
The share leaning toward stopping (1 to 3 on the scale) grows from 3.0% at $10 to 10.2% at $50 and 42.6% at $150 (n=197). The six who would stop even at $10 all took one in the past and say they reject antidepressants on principle, so for them the price is not the reason.
03Who falls away first as the cost rises?
People on lower incomes, and people who have already stopped once. At $150 a month, 18.2% of the 88 adults with a household income under $35,000 rate themselves likely to stay on, against 34.8% of the 69 between $35,000 and $75,000 and 71.8% of the 39 above $75,000. At $50 the gap is smaller: 75.0% under $35,000 and all 39 above $75,000.
The 62 who took an antidepressant in the past but not now fall away much sooner than the 135 who take one today. At $50 a month, 59.7% of past users would stay on against 92.6% of current users; at $150, 19.4% against 42.2%.
04What do people do first when the cost jumps?
They go back to the doctor or the pharmacy counter before they stop. Asked what they would do first if a helpful antidepressant went from $10 to $150 a month, 58.9% (n=197) would ask their doctor to switch them to a cheaper antidepressant and 34.5% would look for a discount card, coupon or cheaper pharmacy. 3.6% would keep paying and 3.0% would stop taking it. None of the 197 picked taking it less often to make it last longer.
That holds among the people most likely to stop. Of the 84 who lean toward stopping at $150, 57 would first ask their doctor for a cheaper antidepressant, 20 would look for a discount and 6 would stop.
05What would do most to keep people on an antidepressant?
A quick switch when side effects bother them. Asked in general, before any price was mentioned, 51.3% (n=197) say being switched to a different antidepressant as soon as side effects bother them would do most to keep them taking it. 19.8% pick a check-in call or visit with their doctor within the first month, 14.7% knowing in advance that it can take four to six weeks to start working, and 14.2% a lower monthly out-of-pocket cost.
Cost ranks last when asked in general, but once a real price is named it is what moves people: of the 28 who pick a lower cost, 19 lean toward stopping at $150.
06What do people also ask?
- What share of adults on an antidepressant would stay on it at $150 a month? 35.0% (n=197) rate themselves likely to keep taking one that is helping, against 82.2% at $50 and 97.0% at $10.
- At what monthly cost do adults on an antidepressant start to drop off? Between $50 and $150: the share leaning toward stopping grows from 10.2% at $50 to 42.6% at $150 (n=197).
- How many would stop outright if the cost rose to $150 a month? 6 of 197 (3.0%) would stop first, while 58.9% would first ask their doctor for a cheaper antidepressant.
Section 07: What they said, and the interview line it rests on
“I would have to say 1 - certain to stop. Even though it's helping and mental health is really important to me, $150 a month is just way too expensive. I don't have that kind of extra money. All my money goes straight to my rent and bills into envelopes, and there is literally nothing I could give up to afford $150 every single month. When it comes to medication, the main thing for me is whether insurance covers it or if I can get it cheap. If it's too expensive or not covered, I just can't take it.”
Predicted from this line in the interview
“The factor I'm thinking about that is important to me when I think about medications is if my insurance covers it or I can get it for a lower price. The factors that make me not want to take a certain medication over another is if it's more expensive or insurance don't cover it.”
“A jump from $10 to $150 a month is pretty significant, and my first reaction to something increasing that much in price is always to look for an alternative that's less expensive but offers the same quality. I wouldn't just stop taking it or try to ration it by spacing out doses, especially since my medication is what keeps me balanced and mentally stable. But I have a great relationship with my primary care doctor and we keep an open line of communication. So I would reach out to him first, explain the huge price jump, and ask if there's a cheaper generic or alternative antidepressant that works just as effectively without breaking the bank.”
Predicted from this line in the interview
“If it's significant enough, I would possibly look at alternatives that are less expensive and same kind of quality.”
“I would definitely have to say being switched to a different antidepressant as soon as side effects bother you. When I was on antidepressants in my 30s, that was the biggest issue for me. I had one prescription where I couldn't even go out into the sun because it literally felt like my whole body was on fire, and I just had to stop taking it altogether. For me, side effects are a very real thing and they are the main factor whenever I deal with any medication. If a medication is causing crazy or uncomfortable side effects, I'm not going to keep putting that in my body unless there's an immediate option to switch to something with fewer or no side effects that actually works.”
Predicted from this line in the interview
“So I have to say about five years ago, I was in my 30s, I was on antidepressants and stuff like that. I didn't mind it, but what I realized is some of them had side effects. And sometimes I had a prescription once where I couldn't go into the sun. I felt like my whole body was on fire, so I had to stop taking it.”
Section 08: How much should you trust this?
What we would defend
- The price ladder: stated likelihood of staying on one antidepressant that is helping falls from 97.0% to 82.2% to 35.0% (n=197) as its monthly cost goes from $10 to $50 to $150; every clone moves in one direction only, and each step's reasoning names its own price (181, 157 and 197 of 197).
- The income gradient at $150 a month: 18.2% under $35,000 (n=88) against 71.8% above $75,000 (n=39).
- Going back to the doctor as the first step: 58.9% (n=197) would ask for a cheaper antidepressant first, and so would 57 of the 84 who lean toward stopping at $150.
- Side effects ahead of cost when asked in general: 51.3% against 14.2% (n=197); the question came first and only 3 of its 197 answers mention a price from the later questions.
What we would not
- A real-world stopping rate. These are stated likelihoods for one hypothetical medicine at three fixed prices, not a count of people who stopped.
- The zero for taking it less often (0 of 197). People who ration a medicine rarely say so when asked directly, so it is a floor, not a rate.
- The figure at $10 as a reading of cost: the 6 of 197 who would stop even at $10 all took one in the past and reject antidepressants on principle.
- Why people stopped in the past. The study did not ask the clones to recall their own past decisions, because the panel does not hold that history as data for most of them.
- Who qualified: the prescription history of 135 of the 197 was inferred from their interviews rather than stated in them (62 stated it).
The main limitation
Every answer to the five questions after the screener was inferred from what the 197 people said in their interviews about medicines, money and their health rather than stated in them, and the price ladder describes one hypothetical antidepressant with no insurance plan named, so read the cliff as a direction and a rough location, not a measured price elasticity.
Section 09: How was this run?
| Segment | Clones |
|---|---|
| Take an antidepressant for depression now | 135 |
| Took one in the past but not now | 62 |
Question wording as fielded
- Have you ever been prescribed an antidepressant for depression?
- In general, which one of these would do most to keep you taking a daily antidepressant your doctor prescribed for depression?
- Your doctor has prescribed a daily antidepressant for depression. After two months it is helping, the side effects are mild, and your out-of-pocket cost at the pharmacy is $10 a month. On a scale of 1 to 7, where 1 is certain to stop and 7 is certain to keep taking it, how likely are you to keep taking this antidepressant for the next six months?
- Your doctor has prescribed a daily antidepressant for depression. After two months it is helping, the side effects are mild, and your out-of-pocket cost at the pharmacy is $50 a month. On a scale of 1 to 7, where 1 is certain to stop and 7 is certain to keep taking it, how likely are you to keep taking this antidepressant for the next six months?
- Your doctor has prescribed a daily antidepressant for depression. After two months it is helping, the side effects are mild, and your out-of-pocket cost at the pharmacy is $150 a month. On a scale of 1 to 7, where 1 is certain to stop and 7 is certain to keep taking it, how likely are you to keep taking this antidepressant for the next six months?
- Your doctor has prescribed a daily antidepressant for depression that is helping, and its out-of-pocket cost at the pharmacy rises from $10 to $150 a month. Which one of these would you most likely do first?
What was not asked, and why
We named no medicine and no brand, and we did not ask about insurance type, therapy or why anyone stopped in the past. The study had six questions: a screener, one general question about what would keep people on treatment, three prices for the same helpful antidepressant, and one question about what they would do first if the price jumped.
What changed from the obvious question
The obvious question is why people stop an antidepressant, which published surveys already answer with side effects and feeling better. We asked 197 clones of US adults who have been prescribed an antidepressant for depression how likely they would be to stay on one that is helping at $10, $50 and $150 a month, and what they would do first if the price jumped. That puts a price on the access side of staying on treatment, which those surveys do not.
Fielded through Ask Brox on 19 November 2026.
More on Why patients stay on a medicine, and why they stop · Pharma & HCP · Healthcare (US) panel
Ask this of your own customers: humans@brox.ai
Related insights
All in this topic-
Patient adherence breaks at the copay: 48.5% would stop a daily blood pressure pill when it jumps from $15 to $60 a month
48.5% 48.5% would stop the blood pressure pill once its copay rose from $15 to $60 a month, on top of no felt benefit and afternoon tiredness, up from 14.0% with the tiredness alone and 1.5% with no felt benefit alone. (base 200)
Read -
Seeing it work keeps US adults on a statin they cannot feel: a cholesterol test result wins over 92.2% of those not yet certain, home delivery 27.5%, and a $30 a month rise is the top reason to stop below $50,000 a year
98% A follow-up blood test showing cholesterol down by a third lifts the share of US adults very likely to still be taking a daily statin a year later from 74.5% to 98.0%; automatic home delivery every three months at the same $10 a month lifts it to 80.5%. Every case had no side effects and no change in how the person feels. (base 200)
Read -
Side-effect fears hold back 67.0% of US adults from a recommended statin, and a test of their own heart risk, not a lower price, is what would change their minds
67% 67.0% say worry about side effects would most hold them back from starting a statin their doctor recommends while they feel well; 19.5% would rather try diet and exercise first and 2.5% name the monthly cost. (base 200)
Read -
Cash to go ahead with a delayed $3,000 treatment: no US adult would for under $1,000, and 97 of 200 would need the full $3,000
0 There is no cheap nudge. Not one person in 200 would proceed for less than $1,000. (base 200)
Read